Silere’s product platform builds on the technology of neural pain suppression stimulators and the cochlear implant, the most sophisticated neural prosthetic currently in distribution. Much has been learned about the technology used in these devices over the past three decades which further reduces device and business risk. Additionally, there has been significant development and refinement in the surgical methods used to implant these devices and the clinical techniques needed to fit them to patients. Silere’ product leverages existing technology with its proprietary therapeutic proven stimulation methods for alleviating the symptoms of debilitating Tinnitus..
The Silere implantable device, once proven safe and effective, is expected to achieve a reduction in the perception of tinnitus of at least 50% in over 50% of those patients with chronic symptoms. The Silere implantable device offers a unique opportunity to alleviate and mange this troubling condition for active duty troops, veterans, and millions of civilians worldwide.
- Once approved by regulatory authorities and marketed through the medical community, the cost burden of this condition would be greatly reduced.
- Performance for active duty troops might be improved, relieving them of both tinnitus symptoms and its related co-morbidities.
Products described are for investigational use only, and not approved by the FDA. The information provided is for general information purposes only.